Published on in Vol 10, No 1 (2021): January
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/21727, first published
.
Evaluation of Self-Care Activities and Quality of Life in Patients With Type 2 Diabetes Mellitus Treated With Metformin Using the 2D Matrix Code of Outer Drug Packages as Patient Identifier: Protocol for the DePRO Proof-of-Concept Observational Study
Evaluation of Self-Care Activities and Quality of Life in Patients With Type 2 Diabetes Mellitus Treated With Metformin Using the 2D Matrix Code of Outer Drug Packages as Patient Identifier: Protocol for the DePRO Proof-of-Concept Observational Study
1 Pharmaceuticals Medicine, Pharmaceuticals, Medical Excellence & Innovation Management, Data Generation, Bayer Vital GmbH, Leverkusen, Germany
2 Institut Dr Schauerte, Munich, Germany
3 Westdeutsches Diabetes- und Gesundheitszentrum, Düsseldorf, Germany